相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Harmful Effects of NSAIDs among Patients with Hypertension and Coronary Artery Disease
Anthony A. Bavry et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction A Nationwide Cohort Study
Anne-Marie Schjerning Olsen et al.
CIRCULATION (2011)
Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: Mechanisms of COX-2 inhibitor risk to heart disease
Cheng-Huai Ruan et al.
LIFE SCIENCES (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee
Robert M. Levy et al.
ADVANCES IN THERAPY (2010)
Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis
F. Polito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin
Lakshmi Pillai et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
An update on the role of leukotrienes in asthma
Teal S. Hallstrand et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
90-Day oral toxicity study of UP446, a combination of defined extracts of Scutellaria baicalensis and Acacia catechu, in rats
Mesfin Yimam et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension
Jan M. Williams et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Epoxyeicosatrienoic Acids: Novel Mediators of Cardioprotection
Kasem Nithipatikom et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial
Francis K. L. Chan et al.
LANCET (2010)
Regulation of microsomal prostaglandin E-2 synthase-1 and 5-lipoxygenase-activating protein/5-lipoxygenase by 4-hydroxynonenal in human osteoarthritic chondrocytes
Shu-Huang Chen et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update
Mario Sanchez-Borges et al.
PHARMACEUTICALS (2010)
Nonsteroidal Antiinflammatory Drugs and Cyclooxygenase Inhibition in the Gastrointestinal Tract: A Trip From Peptic Ulcer to Colon Cancer
Angel Lanas
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI
J-P Raynauld et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model
Lisa Macrory et al.
BMC VETERINARY RESEARCH (2009)
Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages
D. Altavilla et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Levels of Prostaglandin E Metabolite and Leukotriene E4 Are Increased in the Urine of Smokers: Evidence that Celecoxib Shunts Arachidonic Acid into the 5-Lipoxygenase Pathway
Anna J. Duffield-Lillico et al.
CANCER PREVENTION RESEARCH (2009)
Leukotriene Signaling in Atherosclerosis and Ischemia
Magnus Back
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia-Reperfusion Injury and Septic and Non-Septic Shock
Antonietta Rossi et al.
CURRENT VASCULAR PHARMACOLOGY (2009)
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: A comparison study with methylprednisolone
Sonia Messina et al.
EXPERIMENTAL NEUROLOGY (2009)
Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone
Chiara Bolego et al.
FASEB JOURNAL (2009)
Combination therapies that inhibit cyclooxygenase-2 and leukotriene synthesis prevent disease in murine collagen induced arthritis
G. D. Anderson et al.
INFLAMMATION RESEARCH (2009)
The Safety of Flavocoxid, a Medical Food, in the Dietary Management of Knee Osteoarthritis
Sarah L. Morgan et al.
JOURNAL OF MEDICINAL FOOD (2009)
Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging
Helen Vlassara et al.
KIDNEY INTERNATIONAL (2009)
Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study
Robert M. Levy et al.
NUTRITION RESEARCH (2009)
Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease
Christianne L. Roumie et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs
Matthias Hermann
Current Rheumatology Reports (2009)
Arachidonate 5-lipoxygenase (5-LO) promoter genotype and risk of myocardial infarction: A case-control study
Annette Maznyczka et al.
ATHEROSCLEROSIS (2008)
Combination Chemoprevention of HER2/neu-Induced Breast Cancer Using a Cyclooxygenase-2 Inhibitor and a Retinoid X Receptor-Selective Retinoid
Powel H. Brown et al.
CANCER PREVENTION RESEARCH (2008)
Plasma polyunsaturated fatty acids and the decline of renal function
Fulvio Lauretani et al.
CLINICAL CHEMISTRY (2008)
Leukotriene inhibition in small animal medicine
L. Goodman et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2008)
Analysis of the precision and sensitivity to change of different approaches to assess cartilage loss by quantitative MRI in a longitudinal multicentre clinical trial in patients with knee osteoarthritis
Jean-Pierre Raynauld et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Safety evaluation of a combination, defined extract of Scutellaria baicalensis and Acacia catechu
Bruce P. Burnett et al.
JOURNAL OF FOOD BIOCHEMISTRY (2007)
Mechanisms of disease: Leukotrienes
Marc Peters-Golden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Role of leukotriene B4 receptors in rheumatoid arthritis
Steven Mathis et al.
AUTOIMMUNITY REVIEWS (2007)
The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products
L. Fischer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene
Sabine Seuter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Action of epoxyeicosatrienoic acids on cellular function
Arthur A. Spector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis
Cristina Vidal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis
Haim Shapiro et al.
GUT (2007)
Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's disease Anti-inflammatory Prevention Trial (ADAPT)
Barbara K. Martin et al.
PLOS CLINICAL TRIALS (2006)
Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria
Lucyna Mastalerz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs
Sumapa Chaiamnuay et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
Effect of Celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas
Scott D. Solomon et al.
CIRCULATION (2006)
Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease
Martin Spiecker et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Mechanisms of aspirin sensitivity
Csar Picado
CURRENT ALLERGY AND ASTHMA REPORTS (2006)
Neutrophil-derived leukotriene B4 is required for infl ammatory arthritis
M Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis
B Caldwell et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2006)
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs)
A. L. de Weck et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein
Kelitha Maxis et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis
M. Peters-Golden et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Effect of tepoxalin on renal function in healthy dogs receiving an angiotensin-converting enzyme inhibitor
M Fusellier et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2005)
Cyclooxygenase inhibition and cardiovascular risk
EM Antman et al.
CIRCULATION (2005)
Selective cyclooxygenase 2 inhibitors and cardiovascular events
DH Solomon
ARTHRITIS AND RHEUMATISM (2005)
C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and β-Glucan
DJ Allendorf et al.
JOURNAL OF IMMUNOLOGY (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population
A Helgadottir et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance
G Celik et al.
JOURNAL OF ASTHMA (2005)
The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases
JP Pelletier et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Renal and cardiovascular effects of non-steroidal anti-inflammatories and selective cox 2 inhibitors
G Deray
PRESSE MEDICALE (2004)
The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: Results from a randomized, controlled trial
P Bias et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Relationship between cyclooxygenase-2 inhibition and thrombogenesis
WD Dai et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2004)
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm
L Zhao et al.
NATURE MEDICINE (2004)
Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B4 in osteoarthritic chondrocytes -: Role of transforming growth factor β and eicosanoids
J Martel-Pelletier et al.
ARTHRITIS AND RHEUMATISM (2004)
Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis
JH Dwyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults
DH Solomon et al.
CIRCULATION (2004)
Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: Comparison of nimesulide, meloxicam, and rofecoxib
S Bavbek et al.
JOURNAL OF ASTHMA (2004)
Celecoxib in NSAID-induced cutaneous and respiratory adverse reactions
A Valero et al.
MEDICINA CLINICA (2003)
Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study
BF Zhou et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
5-lipoxygenase and FLAP
M Peters-Golden et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs
C Charlier et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs
J Martel-Pelletier et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis
R Spanbroek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro
B Bau et al.
ARTHRITIS AND RHEUMATISM (2002)
Can the diagnosis of NSAID-induced or Hp-associated gastric ulceration be predicted from histology?
M Vieth et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2002)
Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning
R Bolli et al.
CARDIOVASCULAR RESEARCH (2002)
Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice
M Mehrabian et al.
CIRCULATION RESEARCH (2002)
Study of the role of leukotriene B4 in abnormal function of human subchondral osteoarthritis osteoblasts -: Effects of cyclooxygenase and/or 5-lipoxygenase inhibition
Y Paredes et al.
ARTHRITIS AND RHEUMATISM (2002)
Expression of 5-lipoxygenase in pulmonary artery endothelial cells
YY Zhang et al.
BIOCHEMICAL JOURNAL (2002)
The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2
S Tries et al.
INFLAMMATION RESEARCH (2002)
The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?
PO Lim et al.
JOURNAL OF HYPERTENSION (2002)
Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis
H Nakamura et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2001)
Prostaglandin H synthase and vascular function
ST Davidge
CIRCULATION RESEARCH (2001)
Arachidonic acid as a bioactive molecule
AR Brash
JOURNAL OF CLINICAL INVESTIGATION (2001)
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways
CN Serhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Celecoxib in patients with asthma and aspirin intolerance.
B Dahlen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice
Y Guo et al.
BASIC RESEARCH IN CARDIOLOGY (2000)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Tumor necrosis factor-α generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade
CH Woo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition
F Stanke-Labesque et al.
CARDIOVASCULAR RESEARCH (2000)
Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria
R Asero
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2000)
Effects of celecoxib and naproxen on renal function in the elderly
A Whelton et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
An in vivo approach showing the chemotactic activity of leukotriene B4 in acute renal ischemic-reperfusion injury
E Noiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
